McLeod C, Dymock M, Flanagan KL, Plebanski M, et al. The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old. J Infect 2024 Nov 14:106346. doi: 10.1016/j.jinf.2024.106346.
PMID: 39550007